Search research articles
Contact Us
Filters
Showing results (401-410 of 492) with videos related to
Page
of 50
Sort By:
Anticancer Research
|
March 1, 1997
Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy
X W Tong, I Agoulnik, K Blankenburg, et al.
Cancer Gene Therapy
|
April 30, 2003
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients
John Nemunaitis, Casey Cunningham, Alex W Tong, et al.
Journal of Chemical Information and Computer Sciences
|
February 24, 2001
QSAR models using a large diverse set of estrogens
L M Shi, H Fang, W Tong, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Personality & Social Psychology Bulletin
|
October 18, 2025
Gratitude and Self-Benefiting Obedience: Gratitude Eliciting Dishonest Behavior Out of Obedience
Eddie M W Tong, Gabriel R Lau, Delia X Q Poh, et al.
Leukemia
|
April 11, 2008
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
A Quintás-Cardama, W Tong, T Manshouri, et al.
Psychological Research
|
January 23, 2021
"Speak of the Devil… and he Shall Appear": Religiosity, Unconsciousness, and the Effects of Explicit Priming in the Misperception of Immorality
Myron Tsikandilakis, Man Qing Leong, Zhaoliang Yu, et al.
BMC Bioinformatics
|
July 20, 2005
Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling
H Fang, W Tong, R Perkins, et al.
Leukemia
|
September 19, 2013
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia
W S Stevenson, O G Best, A Przybylla, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Page
of 50
Search research articles
Search
Showing results (401-410 of 492) with videos related to
Sort By:
Page
of 50
Anticancer Research
|
March 1, 1997
Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy
X W Tong, I Agoulnik, K Blankenburg, et al.
Cancer Gene Therapy
|
April 30, 2003
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients
John Nemunaitis, Casey Cunningham, Alex W Tong, et al.
Journal of Chemical Information and Computer Sciences
|
February 24, 2001
QSAR models using a large diverse set of estrogens
L M Shi, H Fang, W Tong, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Personality & Social Psychology Bulletin
|
October 18, 2025
Gratitude and Self-Benefiting Obedience: Gratitude Eliciting Dishonest Behavior Out of Obedience
Eddie M W Tong, Gabriel R Lau, Delia X Q Poh, et al.
Leukemia
|
April 11, 2008
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
A Quintás-Cardama, W Tong, T Manshouri, et al.
Psychological Research
|
January 23, 2021
"Speak of the Devil… and he Shall Appear": Religiosity, Unconsciousness, and the Effects of Explicit Priming in the Misperception of Immorality
Myron Tsikandilakis, Man Qing Leong, Zhaoliang Yu, et al.
BMC Bioinformatics
|
July 20, 2005
Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling
H Fang, W Tong, R Perkins, et al.
Leukemia
|
September 19, 2013
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia
W S Stevenson, O G Best, A Przybylla, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Page
of 50